AstraZeneca
AZN
#47
Rank
A$425.24 B
Marketcap
A$137.15
Share price
0.64%
Change (1 day)
31.28%
Change (1 year)

AstraZeneca (AZN) - P/B ratio

P/B ratio as of December 2025 : 6.21

According to AstraZeneca's latest financial reports the company has a price-to-book ratio of 4.91486.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

AstraZeneca - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-316.0620.53%
2024-12-315.03-5.7%
2023-12-315.33-6.11%
2022-12-315.6822.91%
2021-12-314.62-44.86%
2020-12-318.38-6.58%
2019-12-318.9733.36%
2018-12-316.7228.42%
2017-12-315.2426.54%
2016-12-314.14-11.43%
2015-12-314.672.46%
2014-12-314.5643.05%
2013-12-313.1930.18%
2012-12-312.45-3.97%
2011-12-312.55-8.3%
2010-12-312.78-15.01%
2009-12-313.27-11.54%
2008-12-313.70-11.59%
2007-12-314.18-21.39%
2006-12-315.32-6.66%
2005-12-315.7038.15%
2004-12-314.13-33.21%
2003-12-316.1815.01%
2002-12-315.37

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Bristol-Myers Squibb
BMY
5.94-4.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1.52-75.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
5.05-18.66%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
4.67-24.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
1.36-78.17%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
40.3 548.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
6.25 0.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
4.23-31.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
1.41-77.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5.97-4.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland